Mind Medicine (MindMed) Inc.
General ticker "MNMD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $695.7M (TTM average)
Mind Medicine (MindMed) Inc. follows the US Stock Market performance with the rate: 59.1%.
Estimated limits based on current volatility of 3.1%: low 17.09$, high 18.18$
Factors to consider:
- Total employees count: 74 (+29.8%) as of 2024
- Top business risk factors: Transition to commercialization, Drug development risks, Regulatory and compliance, Cybersecurity threats, Reimbursement risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [7.82$, 19.85$]
- 2026-12-31 to 2027-12-31 estimated range: [5.55$, 14.95$]
Financial Metrics affecting the MNMD estimates:
- Negative: with PPE of -6.0 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -11.24 <= 0.01
- Positive: Shareholder equity ratio, % of 75.51 > 64.29
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term MNMD quotes
Long-term MNMD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $93.87MM | $103.92MM | $166.31MM |
| Operating Income | $-93.87MM | $-103.92MM | $-166.31MM |
| Non-Operating Income | $-1.87MM | $-4.76MM | $-17.48MM |
| Interest Expense | $0.92MM | $2.28MM | $5.48MM |
| R&D Expense | $52.12MM | $65.30MM | $117.67MM |
| Income(Loss) | $-95.73MM | $-108.68MM | $-183.79MM |
| Profit(Loss)* | $-95.73MM | $-108.68MM | $-183.79MM |
| Stockholders Equity | $78.13MM | $241.45MM | $332.33MM |
| Assets | $124.54MM | $302.15MM | $440.10MM |
| Operating Cash Flow | $-64.36MM | $-79.13MM | $-131.56MM |
| Investing Cash Flow | $0.08MM | $-0.03MM | $-151.61MM |
| Financing Cash Flow | $21.85MM | $253.20MM | $267.27MM |
| Earnings Per Share** | $-2.44 | $-1.54 | $-2.06 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.